title: Pathogenesis-based therapies in ichthyoses.
abstract: During the past 20 years, tremendous progress has been made in our understanding of the molecular basis of many genetic skin conditions. The translation of these laboratory findings into effective therapies for affected individuals has been slow, however, in large part due to the risk of carcinogenesis from random viral genomic integration and the lack of efficacy of topically applied genetic material and most proteins. As intervention at the gene level still appears remote for most genetic disorders, increased knowledge about the cellular and biochemical pathogenesis of disease allows specific targeting of pathways with existing and/or novel drugs and molecules. In contrast to the requirement for personalization of most gene-based approaches, pathogenesis-based therapy is pathway specific, and in theory, it should have broader applicability. In this chapter, we provide an overview of the pathoetiology of the various types of ichthyoses and demonstrate how a pathogenesis-based approach can potentially lead to innovative treatments for these conditions. Notably, this strategy has been successfully validated for the treatment of the rare X-linked dominant condition, CHILD syndrome, in which topical applications of cholesterol and lovastatin together to affected skin resulted in marked improvement of the skin phenotype.
authors: St John's Institute of Dermatology, King's College London, London, United Kingdom.
authors: Joey E
authors: JE
authors: Lai-Cheong
authors: Peter M
authors: PM
authors: Elias
authors: Amy S
authors: AS
authors: Paller
mesh_terms: D000015:Abnormalities, Multiple / Q000628:therapy; D000287:Administration, Topical; D002784:Cholesterol / Q000008:administration & dosage*; D004338:Drug Combinations; D040181:Genetic Diseases, X-Linked / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D016113:Ichthyosiform Erythroderma, Congenital / Q000628:therapy; D007057:Ichthyosis / Q000209:etiology* / Q000628:therapy*; D017880:Limb Deformities, Congenital / Q000628:therapy; D008148:Lovastatin / Q000008:administration & dosage*; D010641:Phenotype; D012720:Severity of Illness Index
chemical_list: D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D008148:Lovastatin
references: Nat Genet. 1999 Jul;22(3):291-4
references: 10391219
references: Am J Med Genet. 1998 Jan 13;75(2):145-52
references: 9450875
references: Science. 1981 Nov 6;214(4521):659-60
references: 6945674
references: Cell Res. 2008 Jun;18(6):609-21
references: 18504457
references: J Lipid Res. 2008 Apr;49(4):697-714
references: 18245815
references: Arch Dermatol. 2011 Aug;147(8):993-5
references: 21844472
references: J Clin Invest. 2011 Mar;121(3):976-84
references: 21285510
references: J Invest Dermatol. 1996 May;106(5):1096-101
references: 8618046
references: Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R75-88
references: 12668600
references: J Invest Dermatol. 2011 Nov;131(11):2223-32
references: 21697885
references: Pharm Res. 1992 Aug;9(8):1043-7
references: 1409375
references: Curr Opin Pediatr. 2003 Dec;15(6):607-13
references: 14631207
references: J Lipid Res. 2011 Jan;52(1):6-34
references: 20929975
references: J Invest Dermatol. 2010 Dec;130(12):2736-42
references: 20703245
references: J Invest Dermatol. 2011 Sep;131(9):1947-50
references: 21654837
references: J Invest Dermatol. 2010 Oct;130(10):2497-9
references: 20520629
references: J Invest Dermatol. 2006 Aug;126(8):1770-5
references: 16810297
references: Am J Clin Dermatol. 2009;10(6):351-64
references: 19824737
references: Am J Hum Genet. 2001 Nov;69(5):1002-12
references: 11590543
references: Adv Exp Med Biol. 1999;466:371-6
references: 10709665
references: J Invest Dermatol. 1986 Feb;86(2):187-90
references: 3745944
references: J Invest Dermatol. 2009 Feb;129(2):498-502
references: 18650845
references: J Exp Med. 2009 May 11;206(5):1135-47
references: 19414552
references: J Lipid Res. 2009 Apr;50 Suppl:S213-8
references: 18952574
references: Adv Lipid Res. 1991;24:57-82
references: 1763718
references: J Inherit Metab Dis. 1988;11(4):403-15
references: 2977418
references: Acta Derm Venereol. 2008;88(1):4-14
references: 18176742
references: J Clin Invest. 1981 Dec;68(6):1404-10
references: 6947980
references: J Invest Dermatol. 2011 Nov;131(11):2242-8
references: 21753784
references: J Pharm Sci. 1996 Jun;85(6):643-8
references: 8773963
references: Nat Genet. 1996 Jan;12(1):52-7
references: 8528251
references: Hum Genet. 1979;53(1):65-73
references: 535904
references: Trends Endocrinol Metab. 2000 Apr;11(3):106-14
references: 10707051
references: Eur J Pediatr. 2010 Jan;169(1):121-3
references: 19365639
references: Am J Med Genet A. 2007 Oct 15;143A(20):2371-81
references: 17853487
references: J Lipid Res. 1993 Oct;34(10):1755-64
references: 7504046
references: Am J Med Genet. 2000 Oct 2;94(4):300-5
references: 11038443
references: Pediatr Res. 2009 Jun;65(6):681-5
references: 19430384
references: J Invest Dermatol. 2012 Mar;132(3 Pt 2):820-8
references: 22158553
references: N Engl J Med. 1987 Mar 5;316(10):570-5
references: 2880291
references: J Inherit Metab Dis. 1989;12 Suppl 2:358-60
references: 2512444
references: Biochim Biophys Acta. 2009 Oct;1788(10):2169-73
references: 19616511
references: Nat Genet. 2003 Apr;33(4):508-13
references: 12652302
references: Acta Paediatr Suppl. 2006 Apr;95(451):16-23
references: 16720460
references: Biochem J. 2009 May 13;420(2):305-15
references: 19260826
references: Neuropediatrics. 2001 Jun;32(3):113-22
references: 11521206
references: Hum Genet. 1985;70(3):200-6
references: 3894210
references: Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1536-41
references: 19188585
references: Nat Genet. 1999 Jul;22(3):286-90
references: 10391218
references: Arch Dermatol Res. 1985;277(4):284-7
references: 4004327
references: Dermatoendocrinol. 2011 Apr;3(2):100-6
references: 21695019
references: J Invest Dermatol. 2009 Jun;129(6):1319-21
references: 19434086
references: Annu Rev Genomics Hum Genet. 2001;2:299-341
references: 11701653
references: Nat Genet. 2000 Jun;25(2):141-2
references: 10835624
references: J Biol Chem. 2011 Jul 8;286(27):24046-56
references: 21558561
references: Nat Genet. 1997 Oct;17(2):190-3
references: 9326940
references: J Invest Dermatol. 2010 May;130(5):1237-48
references: 20090767
references: J Invest Dermatol. 1998 Nov;111(5):784-90
references: 9804339
references: Clin Genet. 2005 Nov;68(5):383-91
references: 16207203
references: Biophys J. 2008 Sep;95(5):2340-55
references: 18515391
references: J Invest Dermatol. 2011 Nov;131(11):2169-73
references: 21997416
references: Br J Dermatol. 1999 Sep;141(3):406-14
references: 10583043
references: J Invest Dermatol. 2004 Feb;122(2):314-9
references: 15009711
references: J Clin Invest. 1984 Oct;74(4):1414-21
references: 6592175
references: Mol Cell Proteomics. 2010 Jul;9(7):1461-75
references: 20305089
references: J Exp Med. 2005 Aug 15;202(4):541-9
references: 16103410
references: J Invest Dermatol. 2008 Jan;128(1):104-9
references: 17611579
references: Am J Med Genet. 2000 Feb 14;90(4):328-35
references: 10710233
references: Arch Dermatol Res. 2010 Aug;302(6):443-51
references: 20049467
references: Hum Mol Genet. 2003 Jul 1;12(13):1631-41
references: 12812989
references: Arch Dermatol. 2006 Jul;142(7):914-8
references: 16847209
references: Am J Hum Genet. 2002 Oct;71(4):952-8
references: 12189593
references: Am J Med Genet. 2002 Dec 15;113(4):315-9
references: 12457401